Clinical trial

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

NCT02361424

Study summary

ClinicalTrials.gov

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention PXT00864 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhasePHASE2

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

PXT00864DRUG

placeboDRUG

Sponsors & collaborators

Pharnext S.C.A.lead sponsor

Ascopharm Groupe Novascocollaborator

Mapped research locations

BordeauxFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02361424 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.